Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the development of Full Spectrum Profiling technology, the Chief Executive Officer & Chairman ensures the company maintains a competitive edge in the biotechnology sector. This leadership role involves constant engagement with the Board to align research initiatives with market demands across North America, Europe, and Asia. Wenbin Jiang drives the expansion of the product portfolio, including the Aurora and Northern Lights systems, to meet the evolving needs of scientific research laboratories. Through rigorous oversight of global operations, the Chief Executive Officer & Chairman fosters innovation in cell analysis tools. Ultimately, the executive secures the company's position as a leader in high-sensitivity research services while maintaining operational excellence and sustainable growth across all international markets.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages the fiscal health and capital allocation strategies for the enterprise. Overseeing financial planning and analysis, the Chief Financial Officer ensures the company possesses the necessary resources to support research and development of advanced cell analysis tools. This leadership role involves coordinating with the executive team to optimize revenue streams from the Aurora and Northern Lights systems. William McCombe drives the financial infrastructure required to support global operations across North America, Europe, and Asia. By monitoring market trends in the biotechnology sector, the Chief Financial Officer mitigates fiscal risks and enhances shareholder value. The executive maintains strict compliance with international financial regulations while supporting the scaling of manufacturing and distribution channels. Ultimately, McCombe secures the long-term financial stability required to sustain the company's mission of providing high-resolution cell analysis solutions to scientific research institutions.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, architects the technical roadmap for the company's proprietary Full Spectrum Profiling technology. Overseeing the research and development teams, the Chief Technology Officer drives the innovation of high-sensitivity instruments like the Aurora and Northern Lights systems. This leadership role involves collaborating with engineering departments to refine cell analysis software and hardware capabilities. Ming Yan ensures that all technological advancements meet the rigorous standards required by scientific research laboratories and clinical environments in the European Union and China. By directing the integration of new reagents and supporting software, the Chief Technology Officer maintains the company's status as a pioneer in biotechnology. The executive manages the technical lifecycle of products to ensure high-resolution performance across global markets. Ultimately, Yan secures the technological superiority of the product portfolio, directly impacting the company's ability to provide comprehensive solutions for complex cell analysis.

Ilan Feuchtwang, the Chief Legal Officer at Cytek Biosciences, manages the legal framework and intellectual property portfolio essential to the company's biotechnology operations. Overseeing regulatory compliance, the Chief Legal Officer ensures that all products, including the Northern Lights CLC system, adhere to international standards for clinical use. This leadership role involves navigating complex legal landscapes across North America, Europe, and Asia to protect the company's patented Full Spectrum Profiling technology. Ilan Feuchtwang drives the legal strategy for global distribution channels and business-to-business partnerships. By mitigating legal risks and managing corporate governance, the Chief Legal Officer supports the executive team in achieving strategic growth objectives. The executive provides guidance on contractual obligations and regulatory filings to maintain operational integrity. Ultimately, Feuchtwang secures the company's intellectual assets and ensures that all research services remain compliant with regional biotechnology regulations, facilitating the seamless delivery of cell analysis tools to scientific institutions.